Brief: Societal Cdmo Selected By Longboard Pharmaceuticals To Provide Cdmo Services To Support Clinical Development Of Lp352
05/04/2023 12:32
April 5 (Reuters) - Longboard Pharmaceuticals Inc
LBPH.O :
* SOCIETAL CDMO SELECTED BY LONGBOARD PHARMACEUTICALS TO
PROVIDE
CDMO SERVICES TO SUPPORT CLINICAL DEVELOPMENT OF LP352
Source text for Eikon: ID:nGNXkw012
Further company coverage: LBPH.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Societal CDMO
See all newsBrief: Corerx Inc Completes Acquisition Of Societal CDMO Inc
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview